December 4C due shortly, and Mr. DCB takes the reigns on the 1st of February (he noted he was having a few months off; hi DCB if you are reading this and best of luck).
Noted in bold, from the market annoucement of his role.
I look forward to enriching the strategic, operational and performance drivers within Race Oncology to meet the goals of our investors, the ambitions of our scientists and to deliver a best-in-class clinical program, while unveiling a unique value proposition for the commercial transition of the business.
Look forward to updates in the coming weeks on DCB plan, timelines, status on CMO, role of PL and some guidedance to SH's on their focus for 2023 (I am expecting some info in the 4C).
December 4C due shortly, and Mr. DCB takes the reigns on the 1st...
-
- There are more pages in this discussion • 4,809 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
